Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-18T06:18:43.639Z Has data issue: false hasContentIssue false

Respiratory Syncytial Virus

Published online by Cambridge University Press:  21 June 2016

John T. Sinnott IV*
Affiliation:
Division of Infectious and Tropical Diseases, Department of Internal Medicine, University of South Florida College of Medicine
Lindy S. Gilchrist
Affiliation:
University of South Florida College of Medicine
Leighton Ellis
Affiliation:
Department of Pediatrics, University of South Florida College of Medicine
*
Tampa General Hospital, PO Box 1289, Tampa, FL 33601

Extract

Respiratory syncytial virus (RSV) is the most important cause of lower respiratory tract infection in outpatients, as well as the major viral cause of nosocomial illness in pediatric inpatients. Immunity to this common pathogen is short lived and reinfection can occur later in life, even into adulthood. Virtually all children have one infection before 24 months and 50% experience two or more episodes of infection. The attack rate is substantial with about half of all infants in a community becoming ill during the season's first epidemic. About 100,000 children in the US each year become ill enough to require hospitalization, the hospitalization rate being 1411,000 during epidemic periods. In certain locations, RSV accounts for about 45% of hospital admissions for respiratory disease in children under two years of age.

Information

Type
Special Sections
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1988 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable